Stay updated on Defactinib and VS-6766 in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page.

Latest updates to the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has been updated to reflect a new version of the study on metastatic uveal melanoma, including the addition of collaborators and a revision number, while significant details about the study's objectives and treatment protocols have been removed.SummaryDifference48%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check45 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Defactinib and VS-6766 in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page.